Sovaldi drug analysis - Study guides, Class notes & Summaries

Gilead’s newly formed Access Operations and Emerging Markets (AOEM) division is facing an important yet daunting task of formulating the pricing and distribution strategy for Sovaldi, Gilead’s breakthrough Hepatitis C (HCV) drug. This is not the first time Gilead has introduced a drug capable of having an enormously positive worldwide effect. In the early 2000s, Gilead rose to fame and has since been praised heavily for its extraordinary efforts in combating HIV/AIDS through affordable ...